RecruitingNot ApplicableNCT06823570

Anti-hypertensive Therapy and Exercise Treatment to Improve Vascular Health in Patients With Hypertension.

Anti-hypertensive Therapy and Exercise Treatment to Improve Vascular Health in Patients With Hypertension. A Randomized Controlled Trial.


Sponsor

Heinrich-Heine University, Duesseldorf

Enrollment

60 participants

Start Date

Apr 1, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

This is a prospective, monocentric, randomized controlled trial to investigate the effect of anti-hypertensive treatment and/or individualized exercise training intervention on blood pressure and vascular health. Furthermore the investigators want to decipher mechanisms, which contribute to vascular health by analyzing changes in metabolism and cell function in relation to vascular reaction.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • \- systolic hypertension grade I-II (BP values \>140 mmHg to \<180 mmHg) without anti-hypertensive medication treatment

Exclusion Criteria5

  • no written informed consent
  • age \<18 years
  • isolated diastolic hypertension
  • medical contraindications for the exercise treatment (for example orthopedic problems or an abnormal ECG during the cardio respiratory exercise test)
  • chronic eye diseases on both eyes (for example macular degeneration or glaucoma) or high intraocular pressure (\>20 mmHg)

Interventions

BEHAVIORALIndividualized exercise therapy

Patients in the intervention group will receive an individualized exercise training program 3x/week.

BEHAVIORALLifestyle recommendations

The lifestyle recommendation group will receive general recommendations such as salt reduction, higher physical activity levels and stress reduction.


Locations(1)

Universitätsklinik Düsseldorf

Düsseldorf, Düsseldorf, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06823570


Related Trials